As of 2025-07-01, the Intrinsic Value of Atea Pharmaceuticals Inc (AVIR) is -40.89 USD. This Atea valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.60 USD, the upside of Atea Pharmaceuticals Inc is -1,235.76%.
Based on its market price of 3.60 USD and our intrinsic valuation, Atea Pharmaceuticals Inc (AVIR) is overvalued by 1,235.76%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -40.89 - -40.89 | -40.89 | -1,235.76% |
| P/E | (29.11) - (29.93) | (30.17) | -938.2% |
| DDM - Stable | (9.99) - (27.46) | (18.73) | -620.2% |
| DDM - Multi | (10.01) - (22.30) | (13.92) | -486.7% |
| Market Cap (mil) | 308.09 |
| Beta | 0.63 |
| Outstanding shares (mil) | 85.58 |
| Enterprise Value (mil) | 188.69 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.41% |
| Cost of Debt | 5.00% |
| WACC | 8.67% |